Eyebright Medical Technology (Beijing) Co., Ltd.
SSE:688050.SS
73.8 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,410.022 | 951.177 | 579.497 | 433.071 | 273.049 | 195.198 | 126.973 | 74.811 | 43.529 |
| Cost of Revenue
| 476.178 | 228.231 | 88.352 | 68.041 | 43.936 | 27.941 | 23.655 | 18.619 | 12.389 |
| Gross Profit
| 933.845 | 722.946 | 491.145 | 365.03 | 229.113 | 167.257 | 103.317 | 56.193 | 31.14 |
| Gross Profit Ratio
| 0.662 | 0.76 | 0.848 | 0.843 | 0.839 | 0.857 | 0.814 | 0.751 | 0.715 |
| Reseach & Development Expenses
| 107.198 | 93.644 | 65.963 | 51.915 | 29.991 | 21.677 | 13.81 | 7.012 | 6.769 |
| General & Administrative Expenses
| 57.157 | 34.65 | 22.329 | 18.129 | 10.181 | 9.957 | 26.891 | 23.565 | 11.282 |
| Selling & Marketing Expenses
| 107.457 | 119.452 | 108.024 | 89.922 | 57.254 | 50.414 | 29.11 | 21.001 | 20.556 |
| SG&A
| 164.614 | 152.183 | 130.353 | 108.052 | 67.435 | 60.371 | 56.001 | 44.567 | 31.837 |
| Other Expenses
| 229.032 | 148.503 | 46.644 | 37.459 | 28.379 | 19.969 | -0.04 | 0.014 | 6.171 |
| Operating Expenses
| 500.844 | 395.495 | 242.96 | 197.425 | 125.805 | 102.016 | 80.734 | 56.201 | 39.022 |
| Operating Income
| 433.001 | 327.451 | 259.265 | 184.992 | 111.255 | 69.656 | 26.754 | -3.159 | -9.853 |
| Operating Income Ratio
| 0.307 | 0.344 | 0.447 | 0.427 | 0.407 | 0.357 | 0.211 | -0.042 | -0.226 |
| Total Other Income Expenses Net
| -1.9 | 0.22 | 4.813 | 2.777 | -0.218 | 0.001 | -0.04 | 0.014 | 6.171 |
| Income Before Tax
| 431.1 | 327.671 | 264.078 | 187.769 | 111.037 | 69.657 | 26.714 | -3.145 | -3.683 |
| Income Before Tax Ratio
| 0.306 | 0.344 | 0.456 | 0.434 | 0.407 | 0.357 | 0.21 | -0.042 | -0.085 |
| Income Tax Expense
| 44.017 | 41.619 | 36.847 | 20.015 | 14.92 | 3.9 | 6.406 | 0.963 | -2.193 |
| Net Income
| 388.403 | 303.978 | 232.694 | 171.344 | 96.558 | 66.685 | 20.311 | -3.966 | -1.397 |
| Net Income Ratio
| 0.275 | 0.32 | 0.402 | 0.396 | 0.354 | 0.342 | 0.16 | -0.053 | -0.032 |
| EPS
| 2.05 | 1.61 | 2.21 | 1.63 | 0.92 | 0.63 | 0.28 | -0.06 | -0.02 |
| EPS Diluted
| 2.05 | 1.6 | 2.21 | 1.63 | 0.92 | 0.63 | 0.28 | -0.06 | -0.02 |
| EBITDA
| 597.553 | 423.876 | 318.52 | 228.182 | 137.701 | 94.042 | 40.797 | 1.734 | 3.499 |
| EBITDA Ratio
| 0.424 | 0.446 | 0.55 | 0.527 | 0.504 | 0.482 | 0.321 | 0.023 | 0.08 |